Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EKF DIAGNOSTICS HOLDINGS PLC Board/Management Information 2015

Dec 10, 2015

7617_rns_2015-12-10_b72a0ad9-09f5-4d4f-9177-89d7cbfa48a4.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5855I

EKF Diagnostics Holdings PLC

10 December 2015

EKF Diagnostics Holdings plc

("EKF" or the "Company")

Directorate Changes

EKF Diagnostics Holdings plc (AIM: EKF) announces that Tito Bacarese-Hamilton, Chief Technology Officer, has resigned from the Board with immediate effect and will leave the Company on 31 December 2015.

Dr Bacarese-Hamilton has been granted a share option to acquire 1,300,000 ordinary shares in the Company at an exercise price of 22.5 pence, being the price of an EKF ordinary share on the 30 May 2015. The option can be exercised at any time until 31 December 2016 and has been granted under the Company's Unapproved Share Option Plan. This is the second tranche of three tranches which were to be granted under Dr Bacarese-Hamilton's contract of employment. The third tranche will not be granted.

EKF Diagnostics Holdings plc Tel: 029 2071 0570
Ron Zwanziger, Non-Executive Chairman Tel: +1 339 221 6282
David Evans, Non-Executive Deputy Chairman Mob: 07740 084 452
Julian Baines, CEO Mob: 07788 420 859
Panmure Gordon (UK) Limited Tel: 020 7886 2500
Robert Naylor (Corporate Finance)
Paul Fincham (Corporate Finance)
Walbrook PR Limited Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAEAEANEAFSFAF